cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells

Journal of Cellular Physiology

Volumn 221, Issue 1, 2009, Pages 75-83

  Nagata, Azusa ^a   Tanaka, Tomoaki ^a   Minezawa, Asami ^a   Poyurovsky, Masha ^b   Mayama, Takafumi ^a   Suzuki, Sawako ^a   Hashimoto, Naoko ^a   Yoshida, Tomohiko ^a   Suyama, Keiko ^a   Miyata, Atsuro ^c   Hosokawa, Hiroyuki ^a   Nakayama, Toshinori ^a   Tatsuno, Ichiro ^a  

^a CHIBA UNIVERSITY   (Japan)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' DIDEOXYADENOSINE; ALKALINE PHOSPHATASE; CYCLIC AMP; FORSKOLIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INTERLEUKIN 6; MAXADILAN; MESSENGER RNA; SMALL INTERFERING RNA; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE METABOLISM; CALVARIA; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; ANIMAL; CELL LINE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SECRETION;

ALKALINE PHOSPHATASE; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CYCLIC AMP; GENE EXPRESSION REGULATION; INTERLEUKIN-6; MICE; OSTEOBLASTS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE, TYPE II; RNA, MESSENGER; VASOACTIVE INTESTINAL PEPTIDE;

EID: 69249234736     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21831     Document Type: Article

References (55)

1. Ahlen J, Andersson S, Mukohyama H, Roth C, Backman A, Conaway HH, Lerner UH. 2002. Characterization of the bone-resorptive effect of interleukin-11 in cultured mouse calvarial bones. Bone 31:242-251. (Pubitemid 34754454)
2. Arimura A. 1998. Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn J Physiol 48:301-331. (Pubitemid 28566695)
3. Asnicar MA, KosterA, Heiman ML, Tinsley F, Smith DP, Galbreath E, Fox N, MaYL, Blum WF, Hsiung HM. 2002. Vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating peptide receptor 2 deficiency in mice results in growth retardation and increased basal metabolic rate. Endocrinology 143:3994-4006. (Pubitemid 35244379)
4. Canny BJ, Rawlings SR, Leong DA. 1992. Pituitary adenylate cyclase-activating polypeptide specifically increases cytosolic calcium ion concentration in rat gonadotropes and somatotropes. Endocrinology 130:211-215.
5. Chatterjee TK, Sharma RV, Fisher RA. 1996. Molecular cloning of a novel variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor that stimulates calcium influx by activation of L-type calcium channels. J Biol Chem 271:32226-32232.
6. Christophe J. 1993. Type I receptors for PACAP (a neuropeptide even more important than VIP?). Biochim Biophys Acta 1154:183-199. (Pubitemid 23316612)
7. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G. 2000. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 100:197-207. (Pubitemid 30064908)
8. Fahrenkrug J, Buhl T, Hannibal J. 1995. PreproPACAP-derived peptides occur in VIP-producing tumours and co-exist with VIP. Regul Pept 58:89-98.
9. Fitzgerald J, Hughes-Fulford M. 1999. Mechanically induced c-fos expression is mediated by cAMP in MC3T3-E1 osteoblasts. FASEB J 13:553-557. (Pubitemid 29115573)
10. Grey A, Mitnick MA, Masiukiewicz U, Sun BH, Rudikoff S, Jilka RL, Manolagas SC, Insogna K. 1999. A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo. Endocrinology 140:4683-4690. (Pubitemid 30666136)
11. Harada S, Rodan GA. 2003. Control of osteoblast function and regulation of bone mass. Nature 423:349-355. (Pubitemid 40852710)
12. Hashimoto H, Ishihara T, Shigemoto R, Mori K, Nagata S. 1993. Molecular cloning and tissue distribution of a receptor for pituitary adenylate cyclase-activating polypeptide. Neuron 11:333-342. (Pubitemid 23250350)
13. Hinoi E, Fujimori S, Takemori A, Yoneda Y. 2002. Cell death by pyruvate deficiency in proliferative cultured calvarial osteoblasts. Biochem Biophys Res Commun 294:1177-1183. (Pubitemid 34687174)
14. Hirai A, Nakamura S, Noguchi Y, Yasuda T, Kitagawa M, Tatsuno I, Oeda T, Tahara K, Terano T, Narumiya S, Kohn LD, Saito Y. 1997. Geranylgeranylated rho small GTPase(s) are essential for the degradation of p27Kip1 and facilitate the progression from G1 to S phase in growth-stimulated rat FRTL-5 cells. J Biol Chem 272:13-16. (Pubitemid 27021114)
15. Hosoya M, Onda H, Ogi K, Masuda Y, Miyamoto Y, Ohtaki T, Okazaki H, Arimura A, Fujino M. 1993. Molecular cloning and functional expression of rat cDNAs encoding the receptor for pituitary adenylate cyclase activating polypeptide (PACAP). Biochem Biophys Res Commun 194:133-143. (Pubitemid 23237911)
16. Jones KB, Mollano AV, Morcuende JA, Cooper RR, Saltzman CL. 2004. Bone and brain: A review of neural, hormonal, and musculoskeletal connections. Iowa Orthop J 24:123-132.
17. Journot L, Waeber C, Pantaloni C, Holsboer F, Seeburg PH, Bockaert J, Spengler D. 1995. Differential signal transduction by six splice variants of the pituitary adenylate cyclase-activating peptide (PACAP) receptor. Biochem Soc Trans 23:133-137.
18. Kanno Y, Ishisaki A, Yoshida M, Nakajima K, Tokuda H, Numata O, Kozawa O. 2005. Adenylyl cyclase-cAMP system inhibits thyroid hormone-stimulated osteocalcin synthesis in osteoblasts. Mol Cell Endocrinol 229:75-82.
19. Koh AJ, Beecher CA, Rosol TJ, McCauley LK. 1999. 3′,5′-Cyclic adenosine monophosphate activation in osteoblastic cells: Effects on parathyroid hormone-1 receptors and osteoblastic differentiation in vitro. Endocrinology 140:3154-3162.
20. Konttinen Y, Imai S, Suda A. 1996. Neuropeptides and the puzzle of bone remodeling. State of the art. Acta Orthop Scand 67:632-639.
21. Lerner UH. 1996. Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway. J Bone Miner Res 11:1628-1639.
22. Lundberg P, Lundgren I, Mukohyama H, Lehenkari PP, Horton MA, Lerner UH. 2001. Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: Presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors. Endocrinology 142:339-347. (Pubitemid 32183695)
23. Marks SC, Jr., Cielinski MJ, Sundquist KT. 1996. Bone surface morphology reflects local skeletal metabolism. Microsc Res Tech 33:121-127.
24. Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L, Culler MD, Coy DH. 1989. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164:567-574. (Pubitemid 19269770)
25. Morrow JA, Lutz EM, West KM, Fink G, Harmar AJ. 1993. Molecular cloning and expression of a cDNA encoding a receptor for pituitary adenylate cyclase activating polypeptide (PACAP). FEBS Lett 329:99-105. (Pubitemid 23248258)
26. Nijweide PJ, Burger EH, Feyen JH. 1986. Cells of bone: Proliferation, differentiation, and hormonal regulation. Physiol Rev 66:855-886. (Pubitemid 17181295)
27. Ogi K, Miyamoto Y, Masuda Y, Habata Y, Hosoya M, Ohtaki T, Masuo Y, Onda H, Fujino M. 1993. Molecular cloning and functional expression of a cDNA encoding a human pituitary adenylate cyclase activating polypeptide receptor. Biochem Biophys Res Commun 196:1511-1521. (Pubitemid 23347620)
28. Palmqvist P, Persson E, Conaway HH, Lerner UH. 2002. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. J Immunol 169:3353-3362. (Pubitemid 35013185)
29. Pantaloni C, Brabet P, Bilanges B, Dumuis A, Houssami S, Spengler D, Bockaert J, Journot L. 1996. Alternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipaseC activation. J Biol Chem 271:22146-22151. (Pubitemid 26303846)
30. Persson E, Lerner UH. 2005. The neuropeptide VIP potentiates IL-6 production induced by proinflammatory osteotropic cytokines in calvarial osteoblasts and the osteoblastic cell line MC3T3-E1. Biochem Biophys Res Commun 335:705-711. (Pubitemid 41188256)
31. Persson E, Voznesensky OS, Huang YF, Lerner UH. 2005. Increased expression of interleukin-6 by vasoactive intestinal peptide is associated with regulation of CREB, AP-1 and C/EBP, but not NF-kappaB, in mouse calvarial osteoblasts. Bone 37:513-529. (Pubitemid 41317325)
32. Pfeilschifter J, Koditz R, Pfohl M, Schatz H. 2002. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 23:90-119. (Pubitemid 34185307)
33. Pisegna JR, Wank SA. 1993. Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor. ProcNatl Acad Sci USA 90:6345-6349. (Pubitemid 23191512)
34. Ransjo M, Lie A, Mukohyama H, Lundberg P, Lerner UH. 2000. Microisolated mouse osteoclasts express VIP-1 and PACAP receptors. Biochem Biophys Res Commun 274:400-404. (Pubitemid 30614330)
35. Roodman GD. 2001. Studies in Paget's disease and their relevance to oncology. Semin Oncol 28:15-21. (Pubitemid 32844924)
36. Sakashita Y, Kurihara T, Uchida D, Tatsuno I, Yamamoto T. 2001. Involvement of PACAP receptor in primary afferent fibre-evoked responses of ventral roots in the neonatal rat spinal cord. Br J Pharmacol 132:1769-1776. (Pubitemid 32397969)
37. Sato S, Hanada R, Kimura A, Abe T, Matsumoto T, Iwasaki M, Inose H, Ida T, Mieda M, Takeuchi Y, Fukumoto S, Fujita T, Kato S, Kangawa K, Kojima M, Shinomiya K, Takeda S. 2007. Central control of bone remodeling by neuromedin U. Nat Med 13: 1234-1240. (Pubitemid 47530632)
38. Seki T, Hinohara Y, Taki C, Nakatani M, Ozawa M, Nishimura S, Takaki A, Itho H, Takenoya F, Shioda S. 2006. PACAP stimulates the release of interleukin-6 in cultured rat Muller cells. Ann NY Acad Sci 1070:535-539. (Pubitemid 44126699)
39. Sherwood NM, Krueckl SL, McRory JE. 2000. The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr Rev 21:619-670. (Pubitemid 32113287)
40. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg PH, Journot L. 1993. Differential signal transduction by five splice variants of the PACAP receptor. Nature 365:170-175. (Pubitemid 23282064)
41. Stein GS, Lian JB, Stein JL, Van Wijnen AJ, Montecino M. 1996. Transcriptional control of osteoblast growth and differentiation. Physiol Rev 76:593-629. (Pubitemid 26163716)
42. Strange-Vognsen HH, Arnbjerg J, Hannibal J. 1997. Immunocytochemical demonstration of pituitary adenylate cyclase activating polypeptide (PACAP) in the porcine epiphyseal cartilage canals. Neuropeptides 31:137-141. (Pubitemid 27240054)
43. Suda K, Smith DM, Ghatei MA, Murphy JK, Bloom SR. 1991. Investigation and characterization of receptors for pituitary adenylate cyclase-activating polypeptide in human brain by radioligand binding and chemical cross-linking. J Clin Endocrinol Metab 72:958-964. (Pubitemid 21921791)
44. Suda M, Tanaka K, Fukushima M, Natsui K, Yasoda A, Komatsu Y, Ogawa Y, Itoh H, Nakao K. 1996. C-type natriuretic peptide as an autocrine/paracrine regulator of osteoblast. Evidence for possible presence of bone natriuretic peptide system. Biochem Biophys Res Commun 223:1-6.
45. Sudo H, Kodama HA, Amagai Y, Yamamoto S, Kasai S. 1983. In vitro differentiation and calcification in a newclonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 96:191-198.
46. Suzuki A, Kotoyori J, Oiso Y, Kozawa O. 1994. Pituitary adenylate cyclase-activating polypeptide induces cAMP production independently from vasoactive intestinal polypeptide in osteoblast-like cells. Cell Signal 6:11-16. (Pubitemid 24110324)
47. Tatsuno I, Morio H, Tanaka T, Uchida D, Hirai A, Tamura Y, Saito Y. 1996. Pituitary adenylate cyclase-activating polypeptide (PACAP) is a regulator of astrocytes: PACAP stimulates proliferation and production of interleukin 6 (IL-6), but not nerve growth factor (NGF), in cultured rat astrocyte. Ann NY Acad Sci 805:482-488. (Pubitemid 27058045)
48. Tatsuno I, Uchida D, Tanaka T, Saeki N, Hirai A, Saito Y, Moro O, Tajima M. 2001. Maxadilan specifically interacts with PAC1 receptor, which is a dominant form of PACAP/VIP family receptors in cultured rat cortical neurons. Brain Res 889:138-148. (Pubitemid 32146275)
49. Tintut Y, Parhami F, Le V, Karsenty G, Demer LL. 1999. Inhibition of osteoblast-specific transcription factor Cbfa1 by the cAMP pathway in osteoblastic cells. Ubiquitin/ proteasome-dependent regulation. J Biol Chem 274:28875-28879. (Pubitemid 29477039)
50. Togari A, Arai M, Mizutani S, Mizutani S, Koshihara Y, Nagatsu T. 1997. Expression of mRNAs for neuropeptide receptors and beta-adrenergic receptors in human osteoblasts and human osteogenic sarcoma cells. Neurosci Lett 233:125-128. (Pubitemid 27418180)
51. Uddman R, Tajti J, Hou M, Sundler F, Edvinsson L. 2002. Neuropeptide expression in the human trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2. Cephalalgia 22:112-116. (Pubitemid 34494131)
52. Van Rampelbergh J, Poloczek P, Francoys I, Delporte C, Winand J, Robberecht P, Waelbroeck M. 1997. The pituitary adenylate cyclase activating polypeptide (PACAP I) and VIP (PACAP II VIP1) receptors stimulate inositol phosphate synthesis in transfected CHO cells through interaction with different G proteins. Biochim Biophys Acta 1357:249-255. (Pubitemid 27278049)
53. Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, Vaudry H. 2000. Pituitary adenylate cyclase-activating polypeptide and its receptors: From structure to functions. Pharmacol Rev 52:269-324. (Pubitemid 30368434)
54. Winters SJ, Dalkin AC, Tsujii T. 1997. Evidence that pituitary adenylate cyclase activating polypeptide suppresses follicle-stimulating hormone-beta messenger ribonucleic acid levels by stimulating follistatin gene transcription. Endocrinology 138:4324-4329. (Pubitemid 27408477)
55. Yoshida T, Asanuma M, Grossmann L, Fuse M, Shibata T, Yonekawa T, Tanaka T, Ueno K, Yasuda T, Saito Y, Tatsuno I. 2006. Geranylgeranyl-pyrophosphate (GGPP) synthase is down-regulated during differentiation of osteoblastic cell line MC3T3-E1. FEBS Lett 580:5203-5207. (Pubitemid 44415791)